Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.87M | 8.77M | 7.60M | 6.53M | 5.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.87M | 8.77M | 7.60M | 6.53M | 5.48M |
| Cost of Revenue | 6.33M | 5.63M | 4.89M | 4.09M | 3.31M |
| Gross Profit | 3.53M | 3.13M | 2.71M | 2.43M | 2.17M |
| SG&A Expenses | 5.82M | 5.82M | 5.78M | 5.95M | 6.16M |
| Depreciation & Amortization | 687.20K | 631.20K | 571.00K | 482.30K | 395.90K |
| Other Operating Expenses | 357.80K | 152.20K | -57.50K | -208.50K | -361.90K |
| Total Operating Expenses | 13.20M | 12.23M | 11.19M | 10.31M | 9.50M |
| Operating Income | -3.33M | -3.47M | -3.58M | -3.79M | -4.02M |
| Income Before Tax | -3.50M | -4.01M | -4.50M | -4.72M | -4.98M |
| Income Tax Expenses | -2.37M | -1.20M | 1.20K | 1.60K | 2.00K |
| Earnings from Continuing Operations | -1.13 | -2.81 | -4.50 | -4.73 | -4.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.13M | -2.81M | -4.50M | -4.73M | -4.98M |
| EBIT | -3.33M | -3.47M | -3.58M | -3.79M | -4.02M |
| EBITDA | -2.98M | -3.17M | -3.35M | -3.56M | -3.79M |
| EPS Basic | -0.01 | -0.03 | -0.05 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 |
| EPS Diluted | -0.01 | -0.03 | -0.05 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 618.21M | 507.30M | 396.38M | 316.64M | 236.91M |
| Average Diluted Shares Outstanding | 618.21M | 507.30M | 396.38M | 316.64M | 236.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |